Neurocrine Biosciences, Inc.
MX ˙ BMV ˙ US64125C1099
SecurityMX:NBIX / Neurocrine Biosciences, Inc.
InstitutionExchange Traded Concepts, Llc
Latest Disclosed Ownership3,882 shares
Latest Disclosed Value $ 511,415
Exchange Traded Concepts, Llc reports 12.47% decrease in ownership of NBIX / Neurocrine Biosciences, Inc.

On April 15, 2026 - Exchange Traded Concepts, Llc filed a 13F-HR form disclosing ownership of 3,882 shares of Neurocrine Biosciences, Inc. (MX:NBIX) valued at $511,415 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 14, 2026 disclosing 4,435 shares of Neurocrine Biosciences, Inc.. This represents a change in shares of -12.47% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-15 2026-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 3,882 -553 -12.47 511 -18.76 0.0036
2026-01-14 2025-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,435 2,641 147.21 629 150.60 0.0048
2025-10-14 2025-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,794 -5,369 -74.95 252 -72.11 0.0021
2025-07-10 2025-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 7,163 136 1.94 900 15.83 0.0110
2025-04-17 2025-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 7,027 -1,106 -13.60 777 -30.00 0.0133
2025-01-21 2024-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 8,133 169 2.12 1,110 21.05 0.0221
2024-10-10 2024-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 7,964 1,803 29.26 918 8.14 0.0215
2024-08-13 2024-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 6,161 429 7.48 848 7.34 0.0214
2024-04-15 2024-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,732 -1,479 -20.51 791 -16.84 0.0204
2024-01-05 2023-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 7,211 26 0.36 950 17.57 0.0254
2023-10-18 2023-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 7,185 -53 -0.73 808 18.48 0.0229
2023-07-20 2023-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 7,238 -222 -2.98 683 -9.67 0.0168
2023-04-12 2023-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 7,460 -1,210 -13.96 755 -27.05 0.0207
2023-01-27 2022-12-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 8,670 147 1.72 1,036 14.36 0.0297
2023-01-18 2022-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 8,670 147 1 0.0297
2022-10-07 2022-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 8,523 -429 -4.79 905 3.67 0.0296
2022-07-20 2022-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 8,952 552 6.57 873 10.79 0.0254
2022-04-26 2022-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 8,400 -2,880 -25.53 788 -18.00 0.0158
2022-01-13 2021-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 11,280 5,130 83.41 961 62.88 0.0186
2021-10-18 2021-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 6,150 5,610 1,038.89 590 1,013.21 0.0151
2021-07-30 2021-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 540 -229 -29.78 53 -29.33 0.0017
2021-04-20 2021-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 769 -316 -29.12 75 -27.88 0.0028
2021-01-19 2020-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,085 1,085 104 0.0048
2020-07-15 2020-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -29 -100.00 0 -100.00
2020-04-14 2020-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 29 29 3 0.0016
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.